SGLT2 inhibitors and GLP-1 receptor agonists: the definitive combination?

被引：3
|
作者：
Cervantes, Carlos Escobar [1 ]
机构：
[1] Univ Hosp La Paz, Cardiol Dept, Madrid 28046, Spain
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2024年 / 12卷 / 08期
关键词：
D O I：
10.1016/S2213-8587(24)00183-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：507 / 508
页数：2
相关论文
共 50 条
  • [1] SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
    De Block, Christophe
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05): : 349 - 352
  • [2] GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?
    Nauck, Michael A.
    Meier, Juris J.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 963 - 964
  • [3] Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Tang, Mengyao
    Morieri, Mario Luca
    Kalim, Sahir
    Doria, Alessandro
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025,
  • [4] SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
    Brown, Emily
    Heerspink, Hiddo J. L.
    Cuthbertson, Daniel J.
    Wilding, John P. H.
    LANCET, 2021, 398 (10296): : 262 - 276
  • [5] Type 1 diabetes: Prescription of GLP-1 receptor agonists and SGLT2 inhibitors
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2025, 20 (01) : 23 - 23
  • [6] Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
    Goncalves, Edison
    Bell, David S. H.
    DIABETES THERAPY, 2018, 9 (03) : 919 - 926
  • [7] Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
    Edison Goncalves
    David S. H. Bell
    Diabetes Therapy, 2018, 9 : 919 - 926
  • [8] Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 26 - 28
  • [9] Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians' Years in Practice
    Inoue, Kosuke
    Kazi, Dhruv S.
    Vaduganathan, Muthiah
    Wadhera, Rishi K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025,
  • [10] Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes?
    Packer, Milton
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05): : 461 - 463
12345